These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18632114)

  • 1. Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure.
    Bartholomeu JB; Vanzelli AS; Rolim NP; Ferreira JC; Bechara LR; Tanaka LY; Rosa KT; Alves MM; Medeiros A; Mattos KC; Coelho MA; Irigoyen MC; Krieger EM; Krieger JE; Negrão CE; Ramires PR; Guatimosim S; Brum PC
    J Mol Cell Cardiol; 2008 Aug; 45(2):240-9. PubMed ID: 18632114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exercise training and carvedilol treatment on cardiac function and structure in mice with sympathetic hyperactivity-induced heart failure.
    Medeiros A; Vanzelli AS; Rosa KT; Irigoyen MC; Brum PC
    Braz J Med Biol Res; 2008 Sep; 41(9):812-7. PubMed ID: 18820772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise training improves the net balance of cardiac Ca2+ handling protein expression in heart failure.
    Rolim NP; Medeiros A; Rosa KT; Mattos KC; Irigoyen MC; Krieger EM; Krieger JE; Negrão CE; Brum PC
    Physiol Genomics; 2007 May; 29(3):246-52. PubMed ID: 17244791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative effect of carvedilol and aerobic exercise training therapies on improving cardiac contractility and remodeling in heart failure mice.
    Vanzelli AS; Medeiros A; Rolim N; Bartholomeu JB; Cunha TF; Bechara LR; Gomes ER; Mattos KC; Sirvente R; Salemi VM; Mady C; Negrao CE; Guatimosim S; Brum PC
    PLoS One; 2013; 8(5):e62452. PubMed ID: 23658728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
    Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carvedilol and metoprolol on the mode of death in patients with heart failure.
    Remme WJ; Cleland JG; Erhardt L; Spark P; Torp-Pedersen C; Metra M; Komajda M; Moullet C; Lukas MA; Poole-Wilson P; Di Lenarda A; Swedberg K
    Eur J Heart Fail; 2007 Nov; 9(11):1128-35. PubMed ID: 17716943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
    Sehnert AJ; Daniels SE; Elashoff M; Wingrove JA; Burrow CR; Horne B; Muhlestein JB; Donahue M; Liggett SB; Anderson JL; Kraus WE
    J Am Coll Cardiol; 2008 Aug; 52(8):644-51. PubMed ID: 18702968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.
    Shore S; Aggarwal V; Zolty R
    J Card Fail; 2012 Dec; 18(12):919-24. PubMed ID: 23207080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
    Remme WJ; Torp-Pedersen C; Cleland JG; Poole-Wilson PA; Metra M; Komajda M; Swedberg K; Di Lenarda A; Spark P; Scherhag A; Moullet C; Lukas MA
    J Am Coll Cardiol; 2007 Mar; 49(9):963-71. PubMed ID: 17336720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice.
    Medeiros A; Rolim NP; Oliveira RS; Rosa KT; Mattos KC; Casarini DE; Irigoyen MC; Krieger EM; Krieger JE; Negrão CE; Brum PC
    J Appl Physiol (1985); 2008 Jan; 104(1):103-9. PubMed ID: 17975126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
    Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP
    J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET.
    McBride BF; White CM
    J Clin Pharmacol; 2005 Jan; 45(1):6-24. PubMed ID: 15601801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate.
    Delea TE; Stanford R; Hagiwara M; Edelsberg JS; Oster G
    Int J Cardiol; 2005 Mar; 99(1):117-24. PubMed ID: 15721509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of low and high doses of carvedilol on restoration of cardiac function and calcium-handling proteins in rat failing heart.
    Sun YL; Hu SJ; Wang LH; Hu Y; Zhou JY
    Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):553-60. PubMed ID: 16026515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.